--- title: "VVOS.US (VVOS.US) — Related News" type: "Symbol" locale: "en" url: "https://longbridge.com/en/quote/VVOS.US/news.md" symbol: "VVOS.US" name: "VVOS.US" parent: "https://longbridge.com/en/quote/VVOS.US.md" datetime: "2026-05-20T22:09:12.538Z" locales: - [en](https://longbridge.com/en/quote/VVOS.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/VVOS.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/VVOS.US/news.md) --- # VVOS.US (VVOS.US) — Related News ### [Vivos Therapeutics releases Q1 2026 financials and operations update.](https://longbridge.com/en/news/287115233.md) *2026-05-20T20:12:40.000Z* > Vivos Therapeutics announced a downsizing affecting 500 employees due to a 15% revenue decrease last quarter. The CEO em ### [TRAW Q1'26 Earnings: EPS estimate is (0.56) USD](https://longbridge.com/en/news/286552794.md) *2026-05-15T11:00:03.000Z* > TRAW (Traws Pharma, Inc.) is set to announce its Q1'26 results on May 18, time not specified. The earnings are expected ### [12 Health Care Stocks Moving In Thursday's Intraday Session](https://longbridge.com/en/news/283035792.md) *2026-04-16T17:06:01.000Z* > Psyence Biomedical (PBM) shares surged 151.4% to $7.24, while Achieve Life Sciences (ACHV) rose 36.61% to $4.85. CareDx ### [](https://longbridge.com/en/news/283030993.md) *2026-04-16T15:44:53.000Z* > Vivos Therapeutics shares are trading lower after the company reported worse-than-expected Q4 financial results. ### [Vivos Therapeutics Inc Full Year Sales Increase](https://longbridge.com/en/news/282925793.md) *2026-04-16T02:20:21.000Z* > Vivos Therapeutics Inc (VVOS) reported a full-year loss of $21.17 million, or $2.07 per share, compared to a loss of $11 ### [Vivos Therapeutics | 8-K: FY2025 Revenue: USD 17.44 M](https://longbridge.com/en/news/282900585.md) *2026-04-15T21:16:51.000Z* ### [12 Health Care Stocks Moving In Wednesday's After-Market Session](https://longbridge.com/en/news/282902537.md) *2026-04-15T21:05:48.000Z* > In Wednesday's after-market session, several health care stocks experienced notable movements. BioAtla (NASDAQ:BCAB) ros